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Voxel-based morphometryLate-onset epilepsy (LOE), with onset after 50 years of age, is often attributed to underlying occult cerebro-
vascular disease. LOE is associatedwith a three-fold increase in subsequent stroke risk, therefore it is impor-
tant to improve our understanding of pathophysiology. In this exploratory study, we aimed to determine
whether established structural magnetic resonance imaging markers and novel physiological imaging
markers of occult cerebrovascular disease were more common in patients with LOE than age-matched
controls.
Sixteen patients with LOE (mean age ± SD: 67.6 ± 6.5 years) and 15 age-matched control subjects (mean
age: 65.1 ± 3.9 years) underwent a 3 T MRI scan protocol. T1-weighted images and T2-weighted ﬂuid atten-
uated inversion recovery (FLAIR) images were used to determine cortical grey matter volume and white
matter hyperintensity (WMH) volume respectively, whilst multiple delay time arterial spin labelling
(ASL) images were collected at rest and during a hypercapnic challenge. Cerebral blood ﬂow (CBF) and
arterial arrival time (AAT) were calculated from ASL data under both normocapnic and hypercapnic
conditions. Cerebrovascular reactivity was also calculated for both CBF and AAT relative to the change in
end-tidal CO2.
Patients with LOE were found to have signiﬁcantly lower cortical volume than control subjects (33.8 ± 3.8% of
intracranial volume vs. 38.0 ± 5.5%, p = 0.02) and signiﬁcantly higher WMH volume (1339 ± 1408 mm3 vs.
514 ± 481 mm3, p = 0.047). Baseline whole brain AAT was found to be signiﬁcantly prolonged in patients
with LOE in comparison to control subjects (1539±129ms vs. 1363±167ms, p=0.005). Voxel-based analysis
showed the signiﬁcant prolongation of AAT to be predominantly distributed in the frontal and temporal lobes.
Voxel-based morphometry showed the lower cortical volume to be localised primarily to temporal lobes. No
signiﬁcant differences in CBF or cerebrovascular reactivity were found between the two groups. Baseline
whole brain AAT and cortical volume differences persisted upon further analysis to take account of differences
in smoking history between patients and control subjects.
These ﬁndings suggest that occult cerebrovascular disease is relevant to the pathophysiology of LOE.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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A third of all diagnoses of epilepsy aremade in people over 60 (Tallis
et al., 1991). Late-onset epilepsy (LOE) is increasingly common, and is
often attributed to cerebrovascular disease (CVD). The relationship be-
tween CVD and LOE is easily recognised where there is a history of
stroke, particularly cortical. However, the relationship between LOE
and otherwise occult CVD (oCVD) (whether cortical or subcortical) is
currently less well established yet causality is often invoked. Limited
available evidence from clinical studies suggests, ﬁrstly, a relationship
between vascular risk factors and the risk of LOE (Ng et al., 1993; Li X.
et al., 1997), apart from the relationship that exists through clinicallythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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CVD, particularly cortical infarction but apparently also excess small
vessel disease (SVD) changes, (Roberts et al., 1988; Maxwell et al.,
2013) and thirdly, an excess (almost threefold) risk of stroke in patients
with LOE (Cleary et al., 2004; Chang et al., 2014; Wannamaker et al.,
2015). Recent studies have also found this increased stroke risk to be
not limited to those aged above 50 years but present in patients diag-
nosed with epilepsy as young as 20 years of age (Chang et al., 2014;
Wannamaker et al., 2015).
Potential mechanisms of epileptogenesis in otherwise oCVDmay in-
clude disruption of neurovascular unit integrity; disordered cerebral
metabolism and perfusion; blood–brain barrier dysfunction; and in-
ﬂammation (Shinton et al., 1987; Gibson et al., 2011).
The aim of this study was to obtain exploratory evidence to support
the proposed association between LOE and oCVD, i.e. in subjects with-
out clinical stroke, using structural and physiological magnetic reso-
nance imaging (MRI) measures. Accepted structural MRI markers of
SVD include white matter hyperintensities (WMHs) and reduced grey
matter (GM) volume (Debette and Markus, 2010; Gouw et al., 2011;
Wardlaw et al., 2013). WMHs have themselves been shown to be an
independent risk factor for future stroke (hazard ratio 3.3, 95% CI:
2.6–4.4) (Debette andMarkus, 2010). However, measurements of cere-
brovascular function such as cerebral blood ﬂow (CBF) and cerebrovas-
cular reactivity (CVR) may provide more sensitive and direct measures
of CVD than these structuralmarkers (Glodzik et al., 2011). Arterial spin
labelling (ASL) is an MRI technique which can be used to assess the
physiological effects of CVD by enabling both the measurement of CBF
and arterial arrival time (AAT) — the time it takes for endogenously
labelled blood to reach the tissue (MacIntosh et al., 2010). CVD is also
known to impact CVR (ASL can also probe CVR by measuring the CBF
and AAT response to a hypercapnic stimulus), the ability of blood ves-
sels to vasodilate in response to a stimulus such as hypercapnia
(Terberg et al., 2000; Hajjar et al., 2010). These structural and physio-
logical measures have not previously been investigated in LOE. We
therefore sought to undertake an exploratory study to determine
whether there are signiﬁcant differences between patients with LOE
and controls in (1) WMH and cortical GM volume, and (2) CBF, AAT
and CVR.2. Methods
2.1. Participants
Patients with a diagnosis of LOE (onset over 50 years of age) were
recruited from neurology out-patient clinics in Lancashire between
October 2011 andMarch 2012. Patients with a history of stroke or tran-
sient ischaemic attack, radiological evidence of cortical/subcortical in-
farct N1.5 cm or other structural cause of epilepsy, focal neurological
signs, known aetiology for epilepsy, cognitive dysfunction sufﬁcient to
interferewith daily activities or other signiﬁcantmedical condition like-
ly to complicate assessment or limit participation in the study, were ex-
cluded. Age matched controls without epilepsywere recruited from the
same region (i.e. Lancashire) who otherwise met the same eligibility
criteria as patients. The two groups were matched for age, gender and
cognition. A Montreal Cognitive Assessment (MoCA, http://www.
MoCAtest.org) was undertaken by all participants, with permission for
use of the test.
This study received relevant regulatory approvals, including ethics
(Cheshire Research Ethics Committee), research governance and local
university approvals. Written informed consent was obtained from all
participants.
Existing clinical reports for all patients regarding computerised to-
mography (CT)/MRI/electroencephalogram (EEG) were scrutinised. All
participants underwent an MRI scan on a 3 T Philips Achieva system
using an 8 channel head coil at Salford Royal Hospital.2.2. Imaging protocol
A high resolution T1-weighted structural image was acquired
using a 3D gradient echo sequence with parameters: ﬂip angle 8°,
TR 8.4 ms, TE 3.9 ms, FOV 240 × 192 mm in-plane, 162 contiguous
axial slices of 1 mm thickness. The images were reconstructed to a
voxel size of 1 × 1 × 1 mm.
A T2-weighted ﬂuid-attenuated inversion recovery (FLAIR) image
was acquired with the following parameters: TR 11 s, TI 2.8 s, TE
120 ms, FOV 230 × 182 mm (images were reconstructed to give voxel
size of 0.45 mm in plane), 30 axial slices of 4 mm thickness with
1 mm gap covering the whole brain.
A Look-Locker ASL sequence (Gunther et al., 2001) was used with
STAR labelling (Edelman et al., 1994) and 4 delay times of 800, 1400,
2000, and 2600 ms after labelling, TR: 3500 ms; TE 22 ms; ﬂip angle
40°; 3.5 × 3.5 × 6mm voxels with a 1 mm gap between slices; 15 slices
covering the cerebrum but not the cerebellum with bipolar gradients
added to de-phase fast ﬂowing spins and so act as a ‘vascular crusher’
in order to remove large vessel signal. The labelling slab was 15 cm
with a 10 mm gap between the labelling and imaging regions. 112
pairs of labelled and control images (at each delay time) were collected,
with scan duration approximately 13 min. To allow quantiﬁcation of
CBF an additional scan was acquired with the same scan parameters
as above except for: TR = 10 s and 15 read-out times (800–9200 ms),
in order to estimate the equilibrium magnetisation of the brain.
An additional echo planar image was collected with the same slice
positioning and the same voxel dimensions but with TE = 35 ms to
give typical functional MRI contrast for registration and normalisation
purposes.
During the ASL acquisition a hypercapnic challenge was adminis-
tered as described previously (Al-Bachari et al., 2014). In brief, after
5 min of breathing room air (fromwhich the baseline perfusion images
were extracted) there followed 6 min of hypercapnia, administered
using a non-rebreathing circuit. CO2 ﬂow-rate was altered to ensure
all participants reached an increased end tidal level approximately 1%
above their baseline. End-tidal CO2 (ETCO2), O2, pulse rate and oxygen
saturation were continuously monitored using Powerlab (ADI Instru-
ments, Colorado Springs, USA).2.3. Statistical analysis
Demographic data were compared between groups using un-
paired t-tests or chi-squared tests. Smoking was measured by pack
years and alcohol in units per week. Cortical GM volume and lateral
ventricular volume were measured from the T1-weighted images
on an individual basis using stereological techniques as implement-
ed in the ‘Easymeasure’ software (Garcia-Finana et al., 2003). Intra-
cranial volume (ICV) was also measured in order to normalise the
measures (i.e. make them independent of head size). Isotropic grid
sizes of 15, 10 and 5 mmwere used for ICV, cortex and ventricles re-
spectively. WMH volume was measured from the T2-weighted FLAIR
image using the same stereological technique with a 3 mm in-plane
grid-size performed on every slice (i.e. at 5 mm intervals). This
choice of grid sizes ensured that the coefﬁcient of error of the volume
estimates were always below 5% (Garcia-Finana et al., 2003). Differ-
ences between groups were tested using student t-tests.
ASL data were analysed using in-house MATLAB (Mathworks, MA,
USA) routines using a single blood compartment model (Parkes et al.,
2002), adapted for LL readout as described previously (Al-Bachari
et al., 2014). Baseline CBF and AAT maps were calculated using the
ﬁrst 5 min of ASL data, during breathing of air. CVRmaps were calculat-
ed using subtraction images of CBF and AAT between periods of air
(5min) and hypercapnia (last 5min, omitting the ﬁrstminute of hyper-
capnia to allow equilibrium to be reached) and dividing these by the
value of change in end-tidal CO2 (ΔETCO2) on an individual basis.
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CVRAAT (ΔAAT/ΔETCO2) were calculated using a simple threshold
mask based on the ASL calibration image on an individual basis.
Differences between groupswere tested using student t-tests. Linear re-
gressionwas used to assesswhether therewere any signiﬁcant relation-
ships between the MRI measurements which showed signiﬁcant group
differences.
Voxel-based analysis (VBA) was also performed using the SPM8
software (http://www.ﬁl.ion.ucl.ac.uk/spm/) to compare CBF, AAT and
CVR maps between groups. Image pre-processing in SPM included
(1) motion correction, (2) registration and normalisation of the EPI
image to the EPI templatewithin SPM, and application of this procedure
to the perfusion maps, and (3) smoothing of the normalised images
using a 12 mm full-width-half-maximum (FWHM) kernel. Voxel-
based morphometry (VBM) was performed on the T1-weighted images
in SPM8 following standard procedures (http://www.ﬁl.ion.ucl.ac.uk/
~john/misc/VBMclass10.pdf) including modulation to allow compari-
sons of volumes, proportional scaling to individual intracranial volume
and smoothing using an 8 mm FWHM kernel. Voxel-wise comparisons
of grey matter volume, CBF, AAT, CVRCBF, and CVRAAT between groups
were carried out using a two-sample t-test (unequal variances). Regions
were considered signiﬁcant at a p value of b0.001 uncorrected, with a
cluster size of 100 voxels (at the re-sampled voxel size of 2 mm isotro-
pic), which we feel provides an appropriate balance between type I and
type II errors in view of the exploratory nature of the study (Lieberman
and Cunningham, 2009).
3. Results
3.1. Participants
Eighteen patients with LOE and seventeen controls were recruited.
Two patients and two controls withdrew due to intolerance of the set-
up of the gas apparatus in the scanner. Sixteen patients underwent
the full scanning protocol, but for three only the T1-weighted and
FLAIR imageswere useable due to theirΔETCO2 gas response being out-
side the expected limits (4–12 mm Hg).
Fifteen controls underwent the full protocol but for one, only the
T1-weighted image was useable due to technical problems at the
scanner.
Baseline demographics for the two groups are shown in Table 1. The
two groups were well matched for age, gender, co-morbidities, cogni-
tion and cardiovascular risk factors other than smoking.
All patients presented with symptoms suggestive of focal seizures
with or without secondary generalisation as evaluated by a consultant
neurologist. Additional patient characteristics, including seizure semiol-
ogy, type, EEG ﬁndings, routine clinical brain imaging ﬁndings and re-
sponse to antiepileptic drug treatment, are available in Supplementary
Table 1. They all underwent routine clinical investigations including
CT and/or MRI brain scans alongside baseline scalp EEG. Two patients
also underwent sleep-deprived EEG.
Of the 15 patients for whom baseline clinical imaging results were
available, 9 had CT and/or MRI scans reported as normal; 6 had SVD
documented in either (or both) their CT or (and) MRI report(s).Table 1
Baseline demographics, expressed as mean ± SD.
Controls
n = 15
LOE patients
n = 16
p
Age (years) 65.1 ± 3.9 67.6 ± 6.5 0.5
Gender (% male) 60 56 0.6
Number of CVD risk factors 1 ± 1.1 1.9 ± 1.1 0.08
Smoking history (pack years) 2.4 ± 4.5 10.4 ± 10.6 0.01
Alcohol intake (units per week) 9.3 ± 9.5 5.3 ± 7.0 0.1
Number of co-morbidities 0.7 ± 1.1 1.4 ± 1.3 0.3
MoCA score 28.3 ± 2.7 27.3 ± 2.0 0.4Scalp EEG reports were available for 13 patients. EEG was normal in
6; 1 showed non-speciﬁc changes; 6 showed changes in keeping
with epilepsy of temporal lobe origin, with focal sharp waves and
spikes being reported either unilaterally or bilaterally in the temporal
lobe(s). Two patients whose baseline EEG was reported as normal
underwent a sleep-deprived EEG. Both sleep-deprived EEGs reported
focal sharp waves in the anterior temporal regions in keeping with an
epileptic focus in the temporal lobe.
3.2. Structural measures of oCVD
A comparison of structural measures of oCVD between groups is
shown in Table 2. Patients were found to have both signiﬁcantly lower
cortical GM volume (33.8 ± 3.8% of ICV vs 38.0 ± 5.5%, p = 0.02) and
signiﬁcantly higher WMH volume (1340 ± 1408 mm3 vs 514 ±
481mm3, p= 0.047) than controls. No difference in ventricular volume
between patients and controls was found. VBM demonstrated focal re-
gions of lower grey matter volume in patients compared to controls,
mainly in temporal lobes (Fig. 1 bottom row and Table 3). There was
one region of increased grey matter volume in patients compared to
controls in the right superior frontal gyrus (164 voxels, peak t = 4.4,
peak p b 0.0001, peak MNI coordinates 39 29 50).
The top row shows AAT difference images (patients− controls) and
the middle row shows regions where these differences are signiﬁcant.
The bottom row shows regions of signiﬁcantly lower grey matter vol-
ume in patients compared to controls. t-Statistic maps are thresholded
at p b 0.001 with cluster size 100. The z-coordinate in MNI space is
given.
3.3. Baseline global and regional CBF and AAT
Whole brain baseline CBF was found not to be signiﬁcantly different
between the two groups (Table 4). VBA also failed to show any signiﬁ-
cant regional differences in baseline CBF between groups.
Whole brain baseline AATwas found to be signiﬁcantly longer in pa-
tients than controls (1539 ± 129 ms vs. 1363 ± 167 ms, p = 0.005)
(Table 4). VBA demonstrated widespread regions of increased baseline
AAT in patients by comparison with controls (Fig. 1 top row), with re-
gions of signiﬁcant increase distributed mainly in the temporal and
frontal lobes (Fig. 1 middle row and Table 5).
3.4. Global and regional CVRCBF and CVRAAT
Whole-brain CVRCBF or CVRAAT were not signiﬁcantly different be-
tween patients and controls (Table 4). VBA of CVRCBF did not show
any signiﬁcant regional differences between the two groups, but CVRAAT
showed one region in the right inferior frontal gyrus where CVR re-
sponse was lower in patients by comparison with controls (105 voxels,
peak t = 5.1, peak p = 0.00001, peak MNI coordinates 8−36 18).
There was no signiﬁcant difference in ETCO2 following induction of
hypercapnia between the groups (Table 4).
Linear regression between all pairs ofmeasurements showing signif-
icant group differences (cortical volume, WMH volume and AAT)
showed that cortical volume was signiﬁcantly correlated with WMH
volume (r = −0.43, p = 0.02, n = 31) and with AAT (r = −0.38,
p = 0.05, n = 27) but WMH volume and AAT were not related (r =Table 2
Structural measures of oCVD, expressed as mean ± SD.
Controls
n = 15
Patients
n = 16
p
Ventricular volume (% of ICV) 1.9 ± 0.8 2.3 ± 1.1 0.3
Cortical GM volume
(% of ICV)
38.0 ± 5.5 33.8 ± 3.8 0.02
WMH volume
(mm3)
514 ± 481 1340 ± 1408 0.047
Fig. 1. Regions of prolonged AAT (top and middle rows) and lower grey matter volume (bottom row) in patients compared with controls.
131M.F. Hanby et al. / NeuroImage: Clinical 9 (2015) 128–1330.28, p = 0.2, n = 27). The correlations were largely driven by group
differences, but the relationship between cortical volume and WMH
volume remained signiﬁcant within the control group.
3.5. Additional analysis accounting for differences in smoking history
Given the difference in smoking history between the two groups,we
repeated the analysis with the 4 heaviest smokers from the patient
group removed (rendering the difference in smoking between the
groups as non-signiﬁcant: LOE 6.9 ± 8.5 pack years vs. controls 2.4 ±
4.5 pack years, p = 0.2). AAT remained signiﬁcantly longer in the pa-
tient group compared to controls (1547 ± 128 ms vs. 1363 ± 167 ms,
p = 0.007), and cortical volume signiﬁcantly lower (33.9 ± 3.4% of
ICV vs. 38.0 ± 5.5%, p = 0.03). However, the difference in white matter
lesion volume was no longer signiﬁcant (888 ± 731 mm3 vs. 514 ±
481 mm3, p = 0.2).
4. Discussion
All patients had been diagnosed with LOE associated with focal sei-
zureswith or without secondary generalisation, and had no history oth-
erwise of clinical CVD. The seizure types in this study population are in
keeping with previous studies of seizures in patients aged 50–85 years
(Paradowski and Zagrajek, 2005).
Patient and control groupswerewell matched for all baseline demo-
graphics other than for smoking, with a signiﬁcantly higher pack year
history among patients than controls. Cardiovascular risk factors such
as dyslipidaemia (Li et al., 1997) and hypertension (Ng et al., 1993)Table 3
Regions of lower grey matter volume in patients compared to controls.
Region Cluster size (n voxels) Cluster p (FWE-correc
R mid temporal gyrus BA21 648 0.04
R cerebellum posterior lobe 627 0.05
R mid temporal gyrus BA39 119 0.9
L sup temporal gyrus BA38
L inf frontal gyrus BA47 541 0.08
L inf frontal gyrus BA47
R inf frontal gyrus BA47 111 0.9
L sup temporal gyrus BA22
176 0.7
L supramarginal gyrus BA40
R cerebellum posterior lobe 139 0.8
R sup temporal gyrus BA22
R sup temporal gyrus BA13 314 0.3
R sup temporal gyrus BA22
L precentral gyrus BA6 211 0.6
Thresholded at p b 0.001, cluster size 100. BA = Brodmann area.have already been reported as independent risk factors for LOE.
Smoking is a known risk factor for oCVD (Van Dijk et al., 2008), and
the difference in smoking history between the two groups is unsurpris-
ing. We recognise this as a potential limitation, however re-analysis
with the 4 heaviest smokers removed from the patient group (render-
ing the difference in smoking between the groups as non-signiﬁcant)
showed similar results. Only 6 of the patients3 clinical imaging scan re-
ports documented the presence of otherwise oCVD. This is perhaps un-
surprising given that features of oCVD, for instance,may not be reported
by some radiologists, who simply deem these ﬁndings (perhaps partic-
ularly those of SVD) to be in keeping with ageing.
Patients were found to have signiﬁcantly lower cortical GM volume
and a signiﬁcantly greater WMH volume than controls. These ﬁndings
are in-keeping with those of previous radiological studies (Shorvon
et al., 1984; Roberts et al., 1988; Maxwell et al., 2013). Brain atrophy
in the context of SVD on imaging has been deﬁned as a lower brain
volume unrelated to a speciﬁc macroscopic focal injury such as trauma
or infarction (Wardlaw et al., 2013). In the present study, ventricular
volume did not differ between groups, excluding signiﬁcant central at-
rophy (which is associated with increased ventricular size and basal
ganglia atrophy). We found signiﬁcantly lower cortical GM volume, ac-
companied by, and signiﬁcantly correlated with, signiﬁcantly greater
WMH volume, suggesting that the cortical atrophy in patients with
LOE is related to SVD.
VBM showed that the atrophy was most signiﬁcant in temporal and
frontal regions (Fig. 1 bottom row and Table 3). This is intriguing as it
may relate to the seizure origin, and is in keeping with studies of TLE
(Keller and Roberts, 2008). Diffuse cerebral atrophy is also a commonted) Peak
t value
Peak p value uncorrected Peak MNI coordinates
5.5 b0.0001 53 5−11
4.9 b0.0001 20−86−39
4.9 b0.0001 56−72 12
4.8 b0.0001 −47 9−15
4.3 b0.0001 −41 21−12
3.9 .0003 −48 30−12
4.8 b0.0001 44 27−8
4.5 b0.0001 −66−45 20
3.7 0.0005 −65−48 27
4.4 b0.0001 35−66−49
4.2 0.0001 59−11 9
4.0 0.0002 45−17 9
4.0 0.0002 68−8 8
4.2 0.0001 −39−5 62
Table 4
Physiological measures of oCVD, expressed as mean ± SD.
Controls
n = 14
Patients
n = 13
p
Baseline CBF
(mL/min/100 mL)
37.5 ± 9.0 42.2 ± 26.8 0.5
Baseline AAT (ms) 1363 ± 167 1539 ± 129 0.005
CVRCBF (%Δ/Δmm Hg) 2.1 ± 2.5 1.4 ± 3.8 0.6
CVRAAT (Δms/Δmm Hg) −21.0 ± 6.3 −18.1 ± 14.2 0.5
ΔETCO2 (mm Hg) 7.9 ± 3.8 9.3 ± 3.5 0.3
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(Regesta and Tangenelli, 1992). This same study found no correlation
between grade of atrophy and seizure frequency, suggesting that
atrophy is not a consequence of seizures.
A recent retrospective study found epilepsy associated with
leukoaraiosis to mainly affect the temporal lobe (Gasparini et al.,
2015). However, the authors commented on the issue of whether
epileptogenesis arises from cortical vascular lesions such as cortical
microinfarcts or microhaemorrhage — for which conventional clinical
MRI has inadequate sensitivity, or from subcortical injury due to disrup-
tion of subcortical–cortical connections, being unresolved.
Baseline CBF, when analysed globally or regionally, was not found
to differ between the two groups. Baseline AAT values were signiﬁ-
cantly longer in patients than controls, on both global and regional
analyses.
Given the hypothesis concerning the relevance of oCVD to LOE, it
might be expected that baseline CBF, as well as AAT, would differ be-
tween patients with LOE and controls. Potentially, chronic CVD, even
without other clinical manifestations, might result in compensatory
mechanisms in the brain tomaintain a constant CBF bymeans of chronic
arteriolar vasodilatation and/or recruitment of secondary collateral ves-
sels (Farkas and Luiten, 2001; Derdeyn et al., 2002). Our use of ‘vascular
crushers’ in the ASL sequence removes signal from larger vessels and
‘weights’ the AAT measurements towards the microvasculature from
which we believe this prolongation of AAT in LOE may arise.
Preservation of CBF in patientswith LOEhas been reported previous-
ly in a positron emission tomography study, with reduction in CBF
noted only among patients with both LOE and radiological WMHs (De
Reuck et al., 1996). Other studies investigating CBF in TLE have reported
a marked reduction in CBF in the affected temporal lobe on both inter-
ictal positron emission tomography and ASL maps (Pense et al., 2010;
Boscolo Galazzo et al., 2015). Future studies addressing CBF in the differ-
ent sub-types of LOE are required to clarify this discrepancy.Table 5
Regions of prolonged AAT in patients compared to controls.
Region Cluster size (n voxels) Cluster p (FWE-correc
R mid temporal gyrus BA 21 352 0.4
R sup temporal gyrus BA 39
R mid temporal gyrus BA 37 1156 0.08
R mid temporal gyrus BA 21
R mid temporal gyrus BA 21
510 0.3
R mid temporal gyrus BA 21
R post central gyrus, BA 43 139 0.7
L mid temporal gyrus BA 21
L insula, BA13 571 0.3
L insula, BA13
L fusiform gyrus, BA19
272 0.5
L sup temporal gyrus, BA 39
R inf frontal gyrus, BA 47
254 0.5
R inf frontal gyrus, BA 45
L caudate
184 0.6
L putamen
Thresholded at p b 0.001, cluster size 100. BA = Brodmann area.VBA found patients with LOE to have signiﬁcantly longer baseline
AAT times in widespread brain regions but with the greatest prolonga-
tion within the temporal and frontal lobes. Clearly, it is tempting to
speculate that temporal and/or frontal lobe AAT prolongation may
have pathophysiological relevance in patients with LOE of temporal
and/or frontal lobe origin, but further study would obviously be needed
to conﬁrm this observation, its distribution, and to deﬁne any potential
epileptogenic mechanisms.
There were no signiﬁcant differences in whole brain CVRCBF or
CVRAAT between the two groups and only a small frontal region of
lower CVRAAT in the patient group, suggesting that CVR is largely pre-
served in patients with LOE. This is unexpected in view of the observed
baseline AAT prolongation. If prolonged AAT is indicative of chronic ar-
teriolar vasodilatation then one might expect impaired CVRCBF and
CVRAAT due to reduced capacity for cerebral vasodilatation of the arteri-
oles under hypercapnic conditions. Preserved CVR despite baseline AAT
prolongation in this study might be attributable to the relatively small
sample size, or may indicate that prolonged baseline AAT may be due
to recruitment of secondary collaterals rather than chronic arteriolar
vasodilatation.
There are a number of other MRI markers of CVD that could have
been included in this study, such as microbleeds and lacunes
(Wardlaw et al., 2013), but our imaging protocol could not be extend-
ed. Given the lack of sensitivity of CVR to LOE, future studies may wish
to consider the inclusion of alternative imaging techniques such as sus-
ceptibility weighted imaging and diffusion weighted imaging.5. Conclusions
We have found WMH volume to be signiﬁcantly increased and cor-
tical GM volume to be signiﬁcantly reduced in patients with LOE, by
comparison with age-matched controls. We also found signiﬁcant pro-
longation of baseline AAT, with VBA demonstrating this prolongation
to be predominantly within frontal and temporal lobes. We found no
signiﬁcant differences in CVR measures. These ﬁndings lend further
support to the relevance of oCVD, without other clinical manifestations
in LOE.
Given the small sample size, this work should be viewed as an ex-
ploratory study. Further study is required to conﬁrm and extend these
observations and to better deﬁne potential pathophysiological mecha-
nisms of epileptogenesis, including discrimination of cortical/subcorti-
cal anatomical substrates, as well as potential opportunities for
intervention.ted) Peak
t value
Peak p value uncorrected Peak MNI coordinates
4.8 b0.0001 70−12−14
4.6 b0.0001 54−48 8
4.1 0.0002 48−56 0
3.9 0.0003 64−32−2
4.1 0.0002 −34 36 6
3.8 0.0004 −44 48 4
4.1 0.0002 72−8 20
4.0 0.0002 −62−10−8
4.0 0.0002 −42−10−4
3.8 0.0004 −38−14 12
4.0 0.0002 −40−68−8
3.7 0.0005 −54−58 8
3.8 0.0004 38 24−2
3.8 0.0005 52 26 4
3.8 0.0004 −18 10 12
3.7 0.0005 −26 0 16
133M.F. Hanby et al. / NeuroImage: Clinical 9 (2015) 128–133Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2015.07.016.
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